Heart Trial Analysis Reveals Anti-Inflammatory Effects of GLP-1 Drugs

A clinical re-analysis demonstrates that the diabetes and weight-loss medication semaglutide significantly lowers systemic inflammation. Patients showed measurable reductions in key biological markers within weeks, showing cardiovascular benefits separate from body weight changes.